Cargando…

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study

BACKGROUND AND PURPOSE: To assess neurological manifestations and health‐related quality of life (QoL) 3 months after COVID‐19. METHODS: In this prospective, multicenter, observational cohort study we systematically evaluated neurological signs and diseases by detailed neurological examination and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rass, Verena, Beer, Ronny, Schiefecker, Alois Josef, Kofler, Mario, Lindner, Anna, Mahlknecht, Philipp, Heim, Beatrice, Limmert, Victoria, Sahanic, Sabina, Pizzini, Alex, Sonnweber, Thomas, Tancevski, Ivan, Scherfler, Christoph, Zamarian, Laura, Bellmann‐Weiler, Rosa, Weiss, Günter, Djamshidian, Atbin, Kiechl, Stefan, Seppi, Klaus, Loeffler‐Ragg, Judith, Pfausler, Bettina, Helbok, Raimund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250725/ https://www.ncbi.nlm.nih.gov/pubmed/33682276 http://dx.doi.org/10.1111/ene.14803

Ejemplares similares

Factors associated with impaired quality of life three months after being diagnosed with COVID-19
por: Rass, Verena, et al.
Publicado: (2021)

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
por: Rass, Verena, et al.
Publicado: (2022)

Cognitive dysfunction 1 year after COVID‐19: evidence from eye tracking
por: Carbone, Federico, et al.
Publicado: (2022)

Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae
por: Rass, Verena, et al.
Publicado: (2023)

Brain microdialysate tau dynamics predict functional and neurocognitive recovery after poor-grade subarachnoid haemorrhage
por: Heilig, Marina, et al.
Publicado: (2023)

Clinical Use of Cerebral Microdialysis in Patients with Aneurysmal Subarachnoid Hemorrhage—State of the Art
por: Helbok, Raimund, et al.
Publicado: (2017)

Long-Term Clinical Trajectory of Patients with Subarachnoid Hemorrhage: Linking Acute Care and Neurorehabilitation
por: Lindner, Anna, et al.
Publicado: (2022)

The location of intraparenchymal bleeding determines functional outcome after spontaneous subarachnoid hemorrhage
por: Lindner, Anna, et al.
Publicado: (2022)

Intracerebral Iron Accumulation may be Associated with Secondary Brain Injury in Patients with Poor Grade Subarachnoid Hemorrhage
por: Helbok, Raimund, et al.
Publicado: (2021)

Hemodynamic response during endotracheal suctioning predicts awakening and functional outcome in subarachnoid hemorrhage patients
por: Rass, Verena, et al.
Publicado: (2020)

Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management?
por: Hüfner, Katharina, et al.
Publicado: (2022)

Autoantibodies against neuronal surface proteins in spontaneous subarachnoid and intracerebral haemorrhage
por: Hegen, Harald, et al.
Publicado: (2018)

Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends
por: Sahanic, Sabina, et al.
Publicado: (2020)

Takotsubo Cardiomyopathy in Traumatic Brain Injury
por: Cheah, Chun Fai, et al.
Publicado: (2016)

Who is at risk of poor mental health following COVID-19 outpatient management?
por: Hüfner, K., et al.
Publicado: (2022)

The Importance of P(bt)O(2) Probe Location for Data Interpretation in Patients with Intracerebral Hemorrhage
por: Lindner, Anna, et al.
Publicado: (2020)

Blood Pressure Changes in Association with Nimodipine Therapy in Patients with Spontaneous Subarachnoid Hemorrhage
por: Rass, Verena, et al.
Publicado: (2023)

Early Predictors for Infectious Complications in Patients With Spontaneous Intracerebral Hemorrhage and Their Impact on Outcome
por: Lindner, Anna, et al.
Publicado: (2019)

Brain temperature regulation in poor-grade subarachnoid hemorrhage patients – A multimodal neuromonitoring study
por: Addis, Alberto, et al.
Publicado: (2020)

Risk Factors for Dysphagia and the Impact on Outcome After Spontaneous Subarachnoid Hemorrhage
por: Keser, Tobias, et al.
Publicado: (2019)

Protocolized Brain Oxygen Optimization in Subarachnoid Hemorrhage
por: Rass, Verena, et al.
Publicado: (2019)

The Importance of Probe Location for the Interpretation of Cerebral Microdialysis Data in Subarachnoid Hemorrhage Patients
por: Kofler, Mario, et al.
Publicado: (2019)

Longitudinal profile of iron accumulation in good‐grade subarachnoid hemorrhage
por: Scherfler, Christoph, et al.
Publicado: (2016)

Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry
por: Pizzini, Alex, et al.
Publicado: (2020)

Subarachnoid Hemorrhage is Followed by Pituitary Gland Volume Loss: A Volumetric MRI Observational Study
por: Rass, Verena, et al.
Publicado: (2019)

A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients
por: Kofler, Mario, et al.
Publicado: (2019)

The Loss of Temporal Muscle Volume is Associated with Poor Outcome in Patients with Subarachnoid Hemorrhage: An Observational Cohort Study
por: Kofler, Mario, et al.
Publicado: (2023)

Neuroglucopenia and Metabolic Distress in Two Patients with Viral Meningoencephalitis: A Microdialysis Study
por: Kofler, Mario, et al.
Publicado: (2016)

Early supplemental parenteral nutrition for the achievement of nutritional goals in subarachnoid hemorrhage patients: An observational cohort study
por: Kofler, Mario, et al.
Publicado: (2022)

Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19
por: Gietl, Mario, et al.
Publicado: (2023)

The effect of the volemic and cardiac status on brain oxygenation in patients with subarachnoid hemorrhage: a bi-center cohort study
por: Rass, Verena, et al.
Publicado: (2021)

Caspr2 antibodies in herpes simplex encephalitis: an extension of the spectrum of virus induced autoimmunity? – A case report
por: Berek, Klaus, et al.
Publicado: (2022)

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course
por: Petzer, Verena, et al.
Publicado: (2021)

Persistent Symptoms and IFN-γ-Mediated Pathways after COVID-19
por: Piater, Talia, et al.
Publicado: (2023)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Anaemia, iron homeostasis and pulmonary hypertension: a review
por: Sonnweber, Thomas, et al.
Publicado: (2020)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

The Significance of iron deficiency and anemia in a real-life COPD cohort
por: Pizzini, Alex, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_89qmpfq55racgogmsba8j9qti8